x
|
QUARTERLY
REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE
ACT OF
1934.
|
o
|
TRANSITION
REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF
1934.
|
Delaware
|
36-3688459
|
(State
or Other Jurisdiction of
Incorporation
or Organization)
|
(I.R.S.
Employer
Identification
No.)
|
1001
Cambridge Drive, Elk Grove Village, Illinois
|
60007
|
(Address
of Principal Executive Offices)
|
(Zip
Code)
|
Large
accelerated filer o
|
Accelerated
filer o
|
Non-accelerated
filer x
|
Class
|
Outstanding
at November 1, 2006
|
Common
Stock, par value $0.001 per share
Preferred
Stock Purchase Rights
|
186,767,033
|
1
|
||
1
|
||
1
|
||
2
|
||
3 | ||
4
|
||
5
|
||
14
|
||
17
|
||
17
|
||
17
|
||
17
|
||
18
|
||
19
|
||
Certifications
|
Financial
Statements.
|
September
30,
2006
|
December
31,
2005
|
||||||
(unaudited)
|
|||||||
Assets:
|
|||||||
Current
Assets:
|
|||||||
Cash
and cash equivalents
|
$
|
4,173,382
|
$
|
3,486,430
|
|||
Accounts
receivable, net
|
5,525,774
|
1,677,334
|
|||||
Inventories,
net
|
2,908,698
|
2,715,170
|
|||||
Prepaid
expenses and other
|
120,006
|
253,167
|
|||||
Total
current assets
|
12,727,860
|
8,132,101
|
|||||
Property
and equipment:
|
|||||||
Property
and equipment
|
1,156,434
|
1,037,432
|
|||||
Less:
accumulated depreciation and amortization
|
(785,289
|
)
|
(720,142
|
)
|
|||
Net
property and equipment
|
371,145
|
317,290
|
|||||
Restricted
certificates of deposit
|
161,766
|
242,180
|
|||||
Goodwill
|
13,370,000
|
13,370,000
|
|||||
Intangible
assets, net
|
837,703
|
844,062
|
|||||
Total
assets
|
$
|
27,468,474
|
$
|
22,905,633
|
|||
Liabilities
and Stockholders’ Equity:
|
|||||||
Current
liabilities:
|
|||||||
Accounts
payable
|
$
|
1,609,996
|
$
|
416,095
|
|||
Inventory-related
material purchase accrual
|
236,565
|
530,134
|
|||||
Employee-related
accrued liabilities
|
352,451
|
208,408
|
|||||
Accrued
professional services
|
50,443
|
279,000
|
|||||
Current
portion of Long Term Debt, including related interest, with related
parties
|
11,100,457
|
-
|
|||||
Other
accrued liabilities
|
225,875
|
301,923
|
|||||
Total
current liabilities
|
13,575,787
|
1,735,560
|
|||||
Deferred
facility reimbursement
|
106,250
|
118,988
|
|||||
Notes
and related accrued interest with related parties
|
5,066,255
|
10,520,369
|
|||||
Stockholders’
equity:
|
|||||||
Preferred
stock; 300,000 shares authorized; No shares issued and outstanding
at
September 30, 2006 and December 31, 2005
|
—
|
—
|
|||||
Common
stock ($.001 par value); 250,000,000 shares authorized; 186,597,533
and
183,252,036 shares issued and outstanding at September 30, 2006 and
December 31, 2005, respectively
|
186,597
|
183,252
|
|||||
Additional
paid-in capital (net of unearned compensation)
|
171,671,854
|
170,387,752
|
|||||
Accumulated
deficit
|
(163,138,269
|
)
|
(160,040,288
|
)
|
|||
Total
stockholders’ equity
|
8,720,182
|
10,530,716
|
|||||
Total
liabilities and stockholders’ equity
|
$
|
27,468,474
|
$
|
22,905,633
|
Three
Months Ended
September
30,
|
Nine
Months Ended
September
30,
|
||||||||||||
2006
|
2005
|
2006
|
2005
|
||||||||||
Net
sales
|
$
|
6,433,439
|
$
|
2,037,369
|
$
|
11,205,308
|
$
|
7,814,649
|
|||||
Costs
and expenses:
|
|||||||||||||
Cost
of sales
|
3,850,012
|
772,406
|
6,739,266
|
3,888,088
|
|||||||||
Research
and development
|
452,435
|
419,713
|
1,390,374
|
1,320,873
|
|||||||||
Selling
and marketing
|
989,329
|
450,444
|
2,472,426
|
1,262,315
|
|||||||||
General
and administrative
|
1,093,683
|
824,342
|
3,152,763
|
2,587,643
|
|||||||||
Total
costs and expenses
|
6,385,460
|
2,466,905
|
13,754,830
|
9,058,919
|
|||||||||
Operating
income / (loss)
|
47,979
|
(429,536
|
)
|
(2,549,522
|
)
|
(1,244,270
|
)
|
||||||
Other
income (expense):
|
|||||||||||||
Interest
income
|
45,872
|
28,872
|
97,885
|
37,326
|
|||||||||
Interest
expense
|
(261,007
|
)
|
(195,500
|
)
|
(646,344
|
)
|
(681,960
|
)
|
|||||
(215,135
|
)
|
(166,628
|
)
|
(548,459
|
)
|
(644,634
|
)
|
||||||
Net
loss
|
$
|
(167,156
|
)
|
$
|
(596,164
|
)
|
$
|
(3,097,981
|
)
|
$
|
(1,888,904
|
)
|
|
Basic
and diluted loss per share
|
$
|
(0.00
|
)
|
$
|
(0.00
|
)
|
$
|
(0.02
|
)
|
$
|
(0.01
|
)
|
|
Weighted
average number of common shares outstanding
|
186,105,594
|
176,030,424
|
184,705,066
|
167,158,764
|
Common
Stock
|
Additional
Paid-In
Capital
|
Accumulated
Deficit
|
Total
|
|||||||||||||
Number
of
Shares
|
Amount
|
|||||||||||||||
Balance
at December 31, 2005
|
183,252,036
|
$
|
183,252
|
$
|
170,387,752
|
$
|
(160,040,288
|
)
|
$
|
10,530,716
|
||||||
Exercise
of Stock Options and vesting of Restricted Shares
|
3,345,497
|
3,345
|
254,555
|
—
|
257,900
|
|||||||||||
Equity
Compensation Expense
|
—
|
—
|
1,026,423
|
1,026,423
|
||||||||||||
Short
Swing Profit Recovery
|
—
|
—
|
3,124
|
—
|
3,124
|
|||||||||||
Net
Loss
|
—
|
—
|
—
|
(3,097,981
|
)
|
(3,097,981
|
)
|
|||||||||
Balance
at September 30, 2006
|
186,597,533
|
$
|
186,597
|
$
|
171,671,854
|
$
|
(163,138,269
|
)
|
$
|
8,720,182
|
Nine
Months Ended
September
30,
|
|||||||
2006
|
2005
|
||||||
Operating
Activities:
|
|||||||
Net
loss
|
$
|
(3,097,981
|
)
|
$
|
(1,888,904
|
)
|
|
Adjustments
to reconcile net loss to net cash used in operating
activities:
|
|||||||
Depreciation
and amortization, excluding goodwill
|
105,990
|
103,774
|
|||||
Patent-related
charge
|
0
|
199,819
|
|||||
Non-cash
compensation expense
|
1,026,423
|
784,563
|
|||||
Changes
in operating assets and liabilities
|
(2,535,432
|
)
|
(739,120
|
||||
Net
cash used in operating activities
|
(4,501,000
|
)
|
(1,539,868
|
)
|
|||
Investing
Activities:
|
|||||||
Decrease
/ (Increase) in restricted certificates of deposit
|
80,414
|
51,027
|
|||||
Payment
of patent costs
|
(32,547
|
)
|
(28,503
|
)
|
|||
Acquisition
of property and equipment
|
(120,939
|
)
|
(65,717
|
)
|
|||
Net
cash used in investing activities
|
(73,072
|
)
|
(43,193
|
)
|
|||
Financing
Activities:
|
|||||||
Proceeds
from equity issuance
|
0
|
4,300,000
|
|||||
Proceeds
from Section16b recovery
|
3,124
|
607,223
|
|||||
Proceeds
from debt issuance
|
5,000,000
|
1,000,000
|
|||||
Exercise
of stock options/vesting of restricted stock grants
|
257,900
|
267,117
|
|||||
Net
cash provided by financing activities
|
5,261,024
|
6,174,340
|
|||||
Increase
in cash and cash equivalents
|
686,952
|
4,591,279
|
|||||
Cash
and cash equivalents at beginning of period
|
3,486,430
|
402,391
|
|||||
Cash
and cash equivalents at end of period
|
$
|
4,173,382
|
$
|
4,993,670
|
Three
months ended
September
30, 2005
|
Nine
months ended
September
30, 2005
|
||||||
Net
loss, as reported
|
$
|
(596,000
|
)
|
$
|
(1,889,000
|
)
|
|
Deduct
net change in stock-based employee compensation expense determined
under
fair-value-based method of all rewards, net of tax
|
$
|
22,000
|
$
|
(270,000
|
)
|
||
Pro
forma net loss
|
$
|
(574,000
|
)
|
$
|
(2,159,000
|
)
|
|
Pro
forma net loss per share (basic)
|
$
|
(0.00
|
)
|
$
|
(0.01
|
)
|
|
Pro
forma net loss per share (diluted)
|
$
|
(0.00
|
)
|
$
|
(0.01
|
)
|
Outstanding,
December 31, 2005
|
8,146,436
|
|||
Granted
|
—
|
|||
Forfeited
or canceled
|
(635,000
|
)
|
||
Exercised
|
(1,335,000
|
)
|
||
Outstanding,
September 30, 2006
|
6,176,436
|
Shares
|
Weighted
Average
Grant Date
Fair
Value (per share)
|
||||||
Outstanding,
December 31, 2005
|
None
|
None
|
|||||
Granted
|
13,330,000
|
$
|
0.35
|
||||
Forfeited
or canceled
|
150,000
|
$
|
0.39
|
||||
Vested
|
2,010,000
|
$
|
0.35
|
||||
Outstanding,
September 30, 2006
|
11,170,000
|
$
|
0.35
|
September
30,
2006
|
December
31,
2005
|
||||||
Raw
materials
|
$
|
1,717,000
|
$
|
1,368,000
|
|||
Work
in process
|
696,000
|
443,000
|
|||||
Finished
product
|
496,000
|
904,000
|
|||||
$
|
2,909,000
|
$
|
2,715,000
|
Management’s
Discussion and Analysis of Financial Conditions and Results of
Operations.
|
Contractual
Obligations
|
Payments
Due by Period
|
|||||||||||||||
Year
|
Total
|
Less
than 1
Year
|
1-3
Years
|
3-5
Years
|
More
than
5
Years
|
|||||||||||
Long
Term Debt Obligations
|
$
|
17,852,000
|
—
|
$
|
11,746,000
|
$
|
6,106,000
|
—
|
||||||||
Operating
Lease Obligations
|
$
|
1,459,000
|
$
|
167,000
|
$
|
348,000
|
$
|
374,000
|
$
|
570,000
|
||||||
Total
|
$
|
19,311,000
|
$
|
167,000
|
$
|
12,094,000
|
$
|
6,480,000
|
$
|
570,000
|
Quantitative
and Qualitative Disclosures About Market
Risk.
|
Controls
and Procedures.
|
(a)
|
An
evaluation was performed under the supervision and with the participation
of our management, including our Chief Executive Officer, or CEO,
and
Chief Financial Officer, or CFO, of the effectiveness of the Company’s
disclosure controls and procedures, as such term is defined under
Rule
13a-15(e) promulgated under the Securities Exchange Act of 1934,
as
amended (the “Exchange Act”) as of September 30, 2006. Based on that
evaluation, we, including the CEO and CFO, concluded that our disclosure
controls and procedures are effective to ensure that information
required
to be disclosed by the Company in reports that it files or submits
under
the Exchange Act, is recorded, processed, summarized and reported
as
specified in Securities and Exchange Commission rules and
forms.
|
(b)
|
There
were no changes in our internal control over financial reporting
identified in connection with the evaluation of such controls that
occurred during the most recent fiscal quarter that has materially
affected, or is reasonably likely to materially affect, the Company’s
internal control over financial
reporting.
|
ISCO
International, Inc.
|
||
By:
|
/s/
JOHN THODE
|
|
Mr.John
Thode
|
||
President
and Chief Executive
|
||
Officer
(Principal Executive Officer)
|
||
By:
|
/s/
FRANK CESARIO
|
|
Frank
Cesario
|
||
Chief
Financial Officer (Principal
|
||
Financial
and Accounting Officer)
|
Exhibit
Number
|
Description
of Exhibit
|
|
Certification
by Chief Executive Officer pursuant to Rule 13a-14(a) and 15d-14(a),
as
adopted pursuant to Section 302 of the Sarbanes-Oxley Act of
2002.
|
||
|
||
Certification
by Chief Financial Officer pursuant to Rule 13a-14(a) and 15d-14(a),
as
adopted pursuant to Section 302 of the Sarbanes-Oxley Act of
2002.
|
||
Certification
Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section
906 of
the Sarbanes-Oxley Act of 2002.
|